EV/EBITDA:
12.06-0.21(-1.71%)Summary
- As of today (September 5, 2025), HALO EV/EBITDA is 12.06, with a fall of -0.21 (-1.71%) during the most recent trading session on September 4, 2025.
- Over the past year, HALO EV/EBITDA has dropped by -4.96 (-29.14%).
- HALO EV/EBITDA is now -99.62% below its all-time high of 3171.43.
Performance
HALO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
HALO EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | -1.7% | -1.7% | -1.9% |
1 m1 month | +19.8% | +19.7% | +22.4% |
3 m3 months | +14.9% | +29.1% | +36.3% |
6 m6 months | -2.5% | +17.5% | +26.3% |
ytdytd | +16.0% | +39.8% | +53.5% |
1 y1 year | -29.1% | +7.9% | +18.1% |
5 y5 years | +106.3% | +151.1% | +165.0% |
HALO EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | 12.27 | -1.7% | 10.07 | +19.8% |
3 m | 3-month | 12.27 | -1.7% | 8.94 | +34.9% |
6 m | 6-month | 13.69 | -11.9% | 8.94 | +34.9% |
1 y | 1-year | 17.21 | -29.9% | 8.94 | +34.9% |
3 y | 3-year | 31.91 | -62.2% | 8.94 | +34.9% |
5 y | 5-year | 134.51 | -91.0% | -194.44 | +106.2% |
alltime | all time | 3171.43 | -99.6% | -205.45 | +105.9% |
HALO EV/EBITDA History
Date | Value |
---|---|
2025 | 12.06(+16.0%) |
2024 | 10.40(-19.6%) |
2023 | 12.94(-53.8%) |
2022 | 28.00(+28.0%) |
2021 | 21.87(-42.3%) |
2020 | 37.89(-189.1%) |
2019 | -42.53(+33.7%) |
2018 | -31.82(-203.9%) |
2017 | 30.62(-288.4%) |
2016 | -16.25(-80.9%) |
Date | Value |
---|---|
2015 | -85.29(+361.8%) |
2014 | -18.47(-13.9%) |
2013 | -21.46(+63.8%) |
2012 | -13.10(-73.9%) |
2011 | -50.13(+270.8%) |
2010 | -13.52(+70.3%) |
2008 | -7.94(-52.0%) |
2007 | -16.55(-50.1%) |
2006 | -33.19(+389.5%) |
2005 | -6.78 |
FAQ
- What is Halozyme Therapeutics, Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for Halozyme Therapeutics, Inc.?
- What is HALO EV/EBITDA year-to-date change?
- What is Halozyme Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Halozyme Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of HALO is 12.06
What is the all time high EV/EBITDA for Halozyme Therapeutics, Inc.?
Halozyme Therapeutics, Inc. all-time high EV/EBITDA is 3171.43
What is HALO EV/EBITDA year-to-date change?
Halozyme Therapeutics, Inc. EV/EBITDA has changed by +1.66 (+15.96%) since the beginning of the year
What is Halozyme Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, HALO EV/EBITDA has changed by -4.96 (-29.14%)